Huaren Health(301408.SZ)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
Huaren Health
301408.SZ
Anhui Huaren Health Pharmaceutical Co., Ltd. operates in the medical and healthcare industry. It offers products for oral and throat, nourishing, heat-clearing, respiratory system, and gynecology, as well as provides vitamins and minerals, and detoxifying products. In addition, it provides supplements, and nutrition and health products.
85.39 B
301408.SZMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
B
Drug RetailIndustry
Industry Ranking3/8
Industry medianC
Industry averageB
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE9.87%B
    • Profit Margin3.71%C
    • Gross Margin35.14%C
  • Growth ScoreB
    • Revenue YoY20.17%B
    • Net Profit YoY38.59%B
    • Total Assets YoY12.12%B
    • Net Assets YoY5.56%C
  • Cash ScoreA
    • Cash Flow Margin371.60%A
    • OCF YoY20.17%B
  • Operating ScoreA
    • Turnover1.07A
  • Debt ScoreD
    • Gearing Ratio59.58%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    China's A-share pharmaceutical industry chain continues to strengthen, with Chimin and CMC hitting the daily limit, following TJPC, YIBAI PHARMACEUTICAL, and PKU HEALTHCARE also hitting the daily limit. Previously, Huaren Health, Baheal Medical, SYPM, INNOSTIC, and HRPC, among other stocks, rose more than 5%

    Wallstreetcn·
    SZ
    301017
    +1.76%
    SH
    600488
    -1.67%
    SZ
    301584
    -2.99%
    Wallstreetcn·
    SZ
    301017
    +1.76%
    SH
    600488
    -1.67%
    SZ
    301584
    -2.99%

    Huaren Health released its performance for the first three quarters, with a net profit attributable to the parent company of 157 million yuan, an increase of 45.21%

    Zhitong·
    SZ
    301408
    -1.19%
    Zhitong·
    SZ
    301408
    -1.19%

    Huaren Health: The application for the registration and marketing authorization of Furmaric Acid Voronol Tablets has been accepted

    Zhitong·
    SZ
    301408
    -1.19%
    Zhitong·
    SZ
    301408
    -1.19%

    Huaren Health: The company prefers a prudent integration strategy rather than large-scale expansion

    Zhitong·
    SZ
    301408
    -1.19%
    Zhitong·
    SZ
    301408
    -1.19%

    Huaren Health released its performance for the first half of the year, with a net profit attributable to the parent company of 104 million yuan, an increase of 42.17%

    Zhitong·
    SZ
    301408
    -1.19%
    Zhitong·
    SZ
    301408
    -1.19%
    © 2026 Longbridge｜Disclaimer